Results 101 to 110 of about 2,190 (195)

PREPARATION AND EVALUATION OF NIOSOMES OF BRIMONIDINE TARTRATE AS OCULAR DRUG DELIVERY SYSTEM [PDF]

open access: yes, 2013
Nioosomes of brimonidine tartrate were prepared by film hydration method. The prepared vesicles were evaluated for photomicroscopic characteristics, entrapment efficiency, in vitro, ex- in vitro drug release, in vivo intra ocular pressure lowering ...
,HARISH,GANESH,CHARYULU,SATYNARAYANA, P. PRABHU, MARINA KOLAND, K.VIJAYNARAYAN
core   +1 more source

The Effect of Glaucoma Medication on Choroidal Thickness Measured with Enhanced Depth-Imaging Optical Coherence Tomography [PDF]

open access: yes, 2019
The aim of this study was to examine the effect of the glaucoma medication on Choroidal Thickness (CT) in those with Primary Open-Angle Glaucoma (POAG) and normal cases.
BAYRAKTAR, Serife   +3 more
core   +4 more sources

DESIGN AND EVALUATION OF CONTROLLED-RELEASE OCULAR INSERTS OF BRIMONIDINE-TARTRATE AND TIMOLOL MALEATE [PDF]

open access: yes, 2017
Objective: The current work was attempted to formulate and evaluate a controlled-release matrix-type ocular inserts containing a combination of brimonidine tartrate and timolol maleate, with a view to sustain the drug release in the cul-de-sac of the eye.
B., Preethi G., Kunal, Prashanth
core   +1 more source

Effect of over-the-counter brimonidine tartrate 0.025% ophthalmic solution on pupil size in healthy adults. [PDF]

open access: yesGraefes Arch Clin Exp Ophthalmol, 2021
Nejad M   +5 more
europepmc   +1 more source

Particles from preformed polymers as carriers for drug delivery [PDF]

open access: yes, 2014
Biodegradable and biocompatible polymers are widely used for the encapsulation of drug molecules. Various particulate carriers with different sizes and characteristics have been prepared by miscellaneous techniques.
Elaissari, A.   +5 more
core  

The efficacy and safety of add-on 0.1% brimonidine tartrate preserved with sodium chlorite in on-treatment Japanese normal-tension glaucoma patients [Corrigendum]

open access: yesClinical Ophthalmology, 2015
The efficacy and safety of add-on 0.1% brimonidine tartrate preserved with sodium chlorite in on-treatment Japanese normal-tension glaucoma patients [Corrigendum] Tsumura T, Yoshikawa K, Kimura T, et al. Clin Ophthalmol. 2014;8:1681–1687. 
Tsumura T   +7 more
doaj  

Fluorimetric quantification of brimonidine tartrate in eye drops.

open access: yesIndian journal of pharmaceutical sciences, 2014
A simple and sensitive spectrofluorimetric method has been developed for the estimation of brimonidine tartrate in pure and eye drops. Linearity was obeyed in the range of 0.2-3.0 ΅g/ml in dimethyl formamide as solvent at an emission wavelength (λem) of 530 nm after excitation wavelength (λex) of 389 nm with good correlation coefficient of 0.998.
Sunitha, G   +5 more
openaire   +1 more source

Comparative analysis of PLGA ocuserts of brimonidine tartrate prepared with different methods

open access: yesEuropean Pharmaceutical Journal
The eye is a highly sensitive organ with multiple physiological barriers that limit drug bioavailability and reduce patient compliance. Research studies are still going on to discover a novel drug delivery system for ocular delivery. The current research
Paramjot   +4 more
doaj   +1 more source

Pharmacodynamic approach for proving equivalence of two ophtalmic solutions containing Brimonidine Tartarate 0.2% in healthy volunteers [PDF]

open access: yesHospital Pharmacology, 2018
Introduction: Bromonidine tartarate ophthalmic solution (CAS registry-number: 70359- 46-5) is a relatively selective alpha-2 adrenergic agonist, indicated for the lowering of intraocular pressure in patients with open-angle glaucoma or ocular ...
Hristova-Valcheva Ruska   +6 more
doaj  

Home - About - Disclaimer - Privacy